BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25310533)

  • 1. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Lee KH; Kim BH; Lee S; Lee HS; Jang JJ; Kang GH
    Lab Invest; 2014 Dec; 94(12):1396-405. PubMed ID: 25310533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
    Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
    Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma.
    Hong J; Yuan Y; Wang J; Liao Y; Zou R; Zhu C; Li B; Liang Y; Huang P; Wang Z; Lin W; Zeng Y; Dai JL; Chung RT
    Cancer Res; 2014 Mar; 74(6):1845-56. PubMed ID: 24477596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
    Hong J; Hu K; Yuan Y; Sang Y; Bu Q; Chen G; Yang L; Li B; Huang P; Chen D; Liang Y; Zhang R; Pan J; Zeng YX; Kang T
    J Clin Invest; 2012 Jun; 122(6):2165-75. PubMed ID: 22585575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
    Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
    Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
    Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
    Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG
    Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
    Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
    Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
    Wang HY; Zhang ZX
    Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
    Yuan Y; Mendez R; Sahin A; Dai JL
    Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
    Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
    Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
    World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
    Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
    Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.